Peter A. McCullough, MD, MPH™
Open in Telegram
Physician, author, news commenator, pandemic response, civil liberties, and path forward, www.petermcculloughmd.com
Show more📈 Analytical overview of Telegram channel Peter A. McCullough, MD, MPH™
Channel Peter A. McCullough, MD, MPH™ (@p_mcculloughmd) in the English language segment is an active participant. Currently, the community unites 15 543 subscribers, ranking 1 574 in the Medicine category and 2 406 in the USA region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 15 543 subscribers.
According to the latest data from 08 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -37 over the last 30 days and by -5 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 13.57%. Within the first 24 hours after publication, content typically collects 7.15% reactions from the total number of subscribers.
- Post reach: On average, each post receives 2 109 views. Within the first day, a publication typically gains 1 112 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 26.
- Thematic interests: Content is focused on key topics such as vaccine, covid-19, mrna, peter, medicine.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“Physician, author, news commenator, pandemic response, civil liberties, and path forward, www.petermcculloughmd.com”
Thanks to the high frequency of updates (latest data received on 09 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
15 543
Subscribers
-524 hours
-67 days
-3730 days
Data loading in progress...
Similar Channels
Tags Cloud
Incoming and Outgoing Mentions
---
---
---
---
---
---
Attracting Subscribers
September '26
September '26
+36
in 14 channels
August '26
+116
in 64 channels
Get PRO
July '26
+140
in 94 channels
Get PRO
June '26
+154
in 158 channels
Get PRO
May '26
+199
in 101 channels
Get PRO
April '26
+112
in 68 channels
Get PRO
March '26
+125
in 74 channels
Get PRO
February '26
+108
in 41 channels
Get PRO
January '26
+115
in 49 channels
Get PRO
December '25
+112
in 32 channels
Get PRO
November '25
+142
in 59 channels
Get PRO
October '25
+105
in 61 channels
Get PRO
September '25
+146
in 84 channels
Get PRO
August '25
+179
in 77 channels
Get PRO
July '25
+121
in 45 channels
Get PRO
June '25
+191
in 67 channels
Get PRO
May '25
+195
in 97 channels
Get PRO
April '25
+191
in 43 channels
Get PRO
March '25
+192
in 48 channels
Get PRO
February '25
+246
in 91 channels
Get PRO
January '25
+396
in 112 channels
Get PRO
December '24
+254
in 65 channels
Get PRO
November '24
+249
in 133 channels
Get PRO
October '24
+211
in 62 channels
Get PRO
September '24
+219
in 43 channels
Get PRO
August '24
+226
in 68 channels
Get PRO
July '24
+152
in 84 channels
Get PRO
June '24
+255
in 112 channels
Get PRO
May '24
+365
in 110 channels
Get PRO
April '24
+296
in 104 channels
Get PRO
March '24
+257
in 164 channels
Get PRO
February '24
+254
in 93 channels
Get PRO
January '24
+314
in 126 channels
Get PRO
December '23
+303
in 97 channels
Get PRO
November '23
+273
in 99 channels
Get PRO
October '23
+336
in 103 channels
Get PRO
September '23
+418
in 0 channels
Get PRO
August '23
+480
in 0 channels
Get PRO
July '23
+518
in 0 channels
Get PRO
June '23
+374
in 0 channels
Get PRO
May '23
+473
in 0 channels
Get PRO
April '23
+670
in 0 channels
Get PRO
March '23
+697
in 0 channels
Get PRO
February '23
+951
in 0 channels
Get PRO
January '23
+2 562
in 0 channels
Get PRO
December '22
+6 202
in 0 channels
| Date | Subscriber Growth | Mentions | Channels | |
| 09 September | +2 | |||
| 08 September | +3 | |||
| 07 September | +2 | |||
| 06 September | +5 | |||
| 05 September | +3 | |||
| 04 September | +3 | |||
| 03 September | +9 | |||
| 02 September | +2 | |||
| 01 September | +7 |
Channel Posts
Most Doctors in America Are EMPLOYEES. That Changes What They Can Say.
The independent physician in his own practice is now the exception. The majority work for hospital systems and large groups, with contracts, credentialing committees, and administrators above them. When institutional messaging came down during the pandemic, disagreeing with it meant risking a job, a mortgage, and a license — all at once. That isn't a character flaw, it's a structural condition, and it explains far more than cowardice does. If you want doctors who will level with patients, build a system where doing it isn't career-ending.
@P_McCulloughMD
| 2 |  The Pentagon's Testosterone Screening Plan and the Case for a Safer Path Forward
What the questionnaire and blood tests will find, the real risks of synthetic testosterone for aging men and deployed women, and why botanical alternatives offer the readiness benefits without harms.
@P_McCulloughMD | 1 027 |
| 3 |  Adults Used to Get a Free Shingles Booster Every Time a Kid on the Block Caught Chickenpox
Repeated exposure to circulating varicella quietly reinforced adult immunity — a mechanism nobody designed and nobody was watching. Routine childhood vaccination reduced that exposure, and researchers RAISED this exact question before the program launched. The data since has been genuinely mixed. What isn't in dispute is that a second-order effect this large was foreseeable, was discussed, and was proceeded past anyway. Population-level interventions have population-level consequences. Model them before rollout, not after.
@P_McCulloughMD | 997 |
| 4 |  Drug Ads List Every Side Effect. Vaccine Ads Don't.
Watch a pharmaceutical commercial and half the runtime is the risk disclosure — required, enforced, unavoidable. Vaccine advertising doesn't carry that burden the same way, even though the package inserts document real adverse events. The flu vaccine insert lists Guillain-Barré syndrome. You have NEVER heard that in a commercial. Whatever anyone concludes about any individual product, the disclosure standard shouldn't depend on which regulatory category a manufacturer's product happens to land in. Same airwaves, same rules.
@P_McCulloughMD | 1 098 |
| 5 |  The NIH government protocol for COVID-19 never met the intensity, complexity, and full range of options in the McCullough Protocol™ for patients with acute, high-risk SARS-CoV-2. Sadly, most patients were inadequately treated at home and in the hospital.
@P_McCulloughMD | 1 276 |
| 6 |  Pandemic response was never taught in medical school. When SARS-CoV-2 hit America in 2020, it was a challenge test for the medical orthodoxy. Few passed. I am proud of the doctors and nurses who stepped into the gap preventing hospitalizations and death and the Wellness Company who has carried us forward since 2022. Courtesy Grant Stinchfield.
@P_McCulloughMD | 1 218 |
| 7 |  A Protocol Is a FLOOR, Not a Ceiling
Guidelines exist to set a minimum standard when a clinician has nothing better to go on. They were never meant to outrank the physician looking at an actual patient. During the pandemic that inverted — deviating became a liability exposure and a licensure risk instead of the exercise of judgment it's supposed to be. It's easy to blame individual doctors. It's harder to admit the system made independent thinking personally expensive, then acted surprised when almost nobody did it.
@P_McCulloughMD | 1 423 |
| 8 |  "I Don't See It the Way You See It" Is Not a Diagnosis
A patient who reports a new symptom after an intervention deserves the same workup they'd get if it had appeared out of nowhere. Rule out what's rule-out-able, document what's left, and say plainly when you don't know. People aren't walking away from medicine because a doctor disagreed with them.
They're walking away because they were told their experience DIDN'T HAPPEN. "I don't know, but let's find out" keeps a patient who'd otherwise be building a treatment plan alone at 2am.
@P_McCulloughMD | 1 294 |
| 9 |  RECOVER-VITAL: Why Paxlovid Was Destined to Fail Against Long COVID
The NIH Trial That Treated the Wrong Disease in the Wrong Patients While Ignoring the One Variable That Actually Matters--Spike Protein.
@P_McCulloughMD | 1 220 |
| 10 |  Proving a Drug Works and Proving It's Safe Don't Require the Same Evidence
Efficacy needs a large randomized trial — you're pulling a real signal out of statistical noise, and that takes power. Harm works differently. A small number of stark events is ENOUGH to warrant investigation. That isn't a lowered standard, it's how pharmacovigilance has always worked, and it's the entire reason post-market surveillance exists. The failure mode is demanding trial-grade certainty before anyone will take a safety signal seriously.
@P_McCulloughMD | 1 308 |
| 11 |  +1Coalition for Epidemic Preparedness and Innovation (CEPI) is banking on another laboratory-generated pandemic. Here is what they are doing about it: >75 vaccine candidates being developed for Disease X with > 470 R&D partners. CEPI's business model is heading your way. Courtesy AMI365.
@P_McCulloughMD | 1 484 |
| 12 |  Trump’s Three Bold Steps to Secure America’s Drug Supply Chain
Drug shortages can be a national security risk. This is what the administration has done to ensure you have access to the medications you depend on.
@P_McCulloughMD | 1 470 |
| 13 |  A platform doesn't get approved. Products do.
RSV, flu, cancer — all coming on the same mRNA backbone.
Here's what that backbone can't do: carry a safety record from one product to the next.
Different antigen. Different dose. Different population. Different risk.
Each needs its own trial. Each needs its own scrutiny.
Fast to manufacture is not the same as proven.
@P_McCulloughMD | 1 789 |
| 14 |  Shingles has a 72-hour window. Most people miss it.
Antivirals work best within 3 days of the rash. Start late and your odds of postherpetic neuralgia — nerve pain lasting months or years — go up sharply.
The warning comes before the blisters: burning, itching, or strange sensitivity in a band on one side.
Near your eye? ER. Not tomorrow.
Few conditions where days matter this much.
@P_McCulloughMD | 1 611 |
| 15 |  Watch what a vaccine ad stops talking about.
When the pitch shifts from "prevents shingles" to heart benefits, brain benefits, general wellness — read that.
Those findings come from observational data. Healthier people get vaccinated more. That's the confounder, and it's brutal to eliminate.
One question matters: does it prevent shingles, in a patient like you, at a risk you accept.
The rest is marketing.
@P_McCulloughMD | 1 516 |
| 16 |  The Shingles Shot Scam: What Your Doctor Won't Tell You About the Vaccine Cartel's Latest Push
Shingles vaccine is more potent than chickenpox shot, lasts only 3–5 years, causes serious inflammation, and has zero proven ancillary benefits — despite what the marketing campaign claims.
@P_McCulloughMD | 1 567 |
| 17 |  A Man Without a Spleen Needs Those Vaccines. That's Not the Same Patient as Everyone Else.
Asplenia leaves someone genuinely defenseless against encapsulated bacteria — pneumococcus, meningococcus, Hib — and for that patient the case is overwhelming. Individual risk assessment is what medicine is supposed to be. What it has drifted toward is a single recommendation applied to every body regardless of age, history, or exposure, in a system where uptake is the metric everyone is graded on. Risk stratification isn't a rejection of vaccines. It's the difference between a physician and a protocol.
@P_McCulloughMD | 1 683 |
| 18 |  Most of America's Antibiotics Start as Ingredients Made in India or China
The active pharmaceutical ingredients behind common generics are largely produced overseas, and the last remaining U.S. penicillin fermentation plant closed decades ago. That's a supply chain a trade dispute or a shipping disruption can sever — and antibiotics aren't optional. New domestic production commitments are a real step toward fixing it. Drug shortages hit the poorest and sickest patients first, every time. Making the basics at home isn't protectionism; it's the same logic as any other strategic reserve.
@P_McCulloughMD | 1 608 |
| 19 |  Stay Home When You're Actually Sick. That's the Part We Got Backwards.
Healthy people isolating for months accomplished little. Sick people going in anyway is how transmission actually happens — and it's still normal, still expected, still rewarded in most workplaces. The unglamorous measures do the work: stay home when symptomatic, sleep separately during an acute illness, wash your hands, get real sleep. Nasal rinses and gargles are cheap and low-risk. None of it requires anyone's permission, and it's more within your control than anything an agency recommends.
@P_McCulloughMD | 1 531 |
| 20 |  Apply the Same Standard to Every Death Count, Every Time.
Millions of Americans spent four years arguing that "died with" and "died of" are different things, and they were right to. That standard doesn't get suspended when a different disease is in the headlines. Cause of death should be adjudicated by the coroner, documented, and published — before it becomes a number in a press release. Careful attribution is what separates public health from public relations, and it's the only way any death count earns the trust it's asking for.
@P_McCulloughMD | 1 426 |
